Journal of Family Planning and Reproductive Health Care

What's in this issue
pp. 1-1(1)
Authors: Reader F.; Calder A.; Hobbs B.; Manassiev N.

From the Editor
pp. 3-3(1)
Author: Reader F.

The emergency intrauterine device: an endangered species
pp. 5-5(1)
Author: Reuter S.

The role of the pharmacist in emergency contraception
pp. 7-7(1)
Author: Taylor B.

FFPRHC Guidance: Emergency Contraception (April 2003)
pp. 9-16(8)

Questions for Recommendations for Clinical Practice Emergency Contraception
pp. 16-16(1)

Training and supporting pharmacists to supply progestogen-only emergency contraception
pp. 17-22(6)
Authors: Bacon L.; Savage I.; Cook S.; Taylor B.

Randomised controlled trial assessing the acceptability of GyneFix^® versus Gyne-T380S^® for emergency contraception
pp. 23-29(7)
Authors: D'Souza R.E.; Masters T.; Bounds W.; Guillebaud J.

Comparative trial of the force required for, and pain of, removing GyneFix^® versus Gyne-T380S^® following randomised insertion
pp. 29-31(3)
Authors: D'Souza R.E.; Bounds W.; Guillebaud J.

Comparison of Marie Stopes scalpel and electrocautery no-scalpel vasectomy techniques
pp. 32-34(3)
Authors: Black T.; Francome C.

Emergency contraception: lessons learned from the UK
pp. 35-40(6)
Author: Schenk K.D.

A 6-month pilot of a collaborative clinic between genitourinary medicine services and a young persons' sexual health clinic
pp. 40-42(3)
Authors: Beddard D.; Chandiok S.; James P.; Russell A.

Primary care and sex: too close for comfort?
pp. 43-43(1)
Author: Watson P.

In search of appropriate contraception: horses for courses
pp. 43-44(2)
Author: Edouard L.

Faculty award
pp. 44-44(1)

The members' enquiry service: frequently asked questions September 2001–August 2002 and an illustrative CEU response
pp. 45-47(3)
Authors: de Souza A.; Brechin S.; Penney G.

Evidence-based family planning: finding answers to clinical questions
pp. 48-52(5)
Authors: Crilly M.; Foy R.

Faculty Examinations
pp. 53-53(1)

News roundup
pp. 56-57(2)

A controlled trial of a human papillomavirus type 16 vaccine. Koutsky LA, Ault KA, Wheeler CM, et al. N Engl J Med 2002; 347: 1645-1651
pp. 57-57(1)
Author: Cruikshank M.

Official warnings on thromboembolism risk with oral contraceptives fail to inform users adequately. Berry DC, Raynor DK, Knapp P, et al. Contraception 2002; 66: 305-307
pp. 57-57(1)
Author: Murty J.

Quick Start: a novel oral contraceptive initiation method. Westhoff C, Kerns J, Morroni C, et al. Contraception 2002; 66: 141-145
pp. 57-57(1)
Author: Murty J.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Narod SA, Dube MP, Klijn J, et al. J Natl Cancer Inst 2002; 94(23): 1773-1779
pp. 58-58(1)
Author: Weaver K.

Young women's accounts of factors influencing their use and non-use of emergency contraception: in-depth interview study. Free C, Lee RM, Ogden J. BMJ 2002; 325: 1393-1396
pp. 58-58(1)
Author: Wakley G.

Five-year clinical experiences with Nova T^® 380 copper IUD. Batár I, Kuukankorpi A, Siljander M, et al. Contraception 2002; 66: 309-314
pp. 58-59(2)
Author: Murty J.

Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. von Hertzen H, Piaggio G, Ding J, et al. Lancet 2002; 360(9348): 1803-1810
pp. 59-59(1)
Authors: O'Brien P.

Website reviews
pp. 60-60(1)

Progestogen-only emergency contraception
pp. 60-60(1)
Authors: Gainer E.; Méry C.; Ulmann A.

Recruitment and Journal vacancy
pp. 61-63(3)

Meetings and courses
pp. 64-64(1)